Opportunity Overview
The Maine Department of Health and Human Services, Maine CDC / Disease Surveillance / Infectious Disease Epidemiology Program, maintains an active Willing & Qualified contracting pathway for Tuberculosis Consultant Services. CT NOI 0220260125 covers the current service term from January 1, 2026 through December 31, 2027.
Maine CDC uses these agreements to obtain specialized physician clinical and consulting services needed to identify, treat, and control tuberculosis, including complex cases involving multi-drug resistant TB and comorbid hepatitis or HIV/AIDS.
Current Funding and Providers
The current PJF addendum lists five incumbent agreements totaling $108,000. Four agreements are $14,000 each and the Maine Medical Center agreement is $52,000.
The listed current providers are Maine Medical Partners, Central Maine Medical Center, MaineGeneral Medical Center, Eastern Maine Medical Center, and MaineHealth dba Maine Medical Center. These named providers are incumbents and are not treated as unsent applicants for this exact W&Q opportunity.
Eligibility and Qualification Requirements
Maine CDC states that qualified consultants must be physicians who are board-certified in Infectious Disease or board-certified in Pulmonology, have specialty expertise in tuberculosis identification and treatment, and be able to cover Maine’s wide geographic region.
The State says it will also contract with other willing and qualified providers if they come forward and sufficient funding is available.
Compensation Model
TB consultants are paid using a monthly flat-rate reimbursement fee for clinics and consultations. The PJF states that diagnostics and procedures are reimbursed according to Maine’s Care fee schedule, and that consultants may not bill beyond the flat-rate schedule for consultation time.
Atlas Relevance
This is a specialized infectious-disease clinical-services pathway with clear relevance to diagnostics and public health, but the current procurement is centered on physician expertise rather than equipment acquisition, telehealth infrastructure, or remote-exam technology. No N9+ or device-cost eligibility should be inferred from the current record.
Dr. Miltie is not a viable direct prime provider under the current qualification criteria because the service requires board-certified physician specialists with tuberculosis expertise and statewide coverage capability.
Next Action
Preserve the five named organizations as incumbent providers. For any prospective new consultant or organization, first verify the required board certification, TB expertise, statewide service capacity, current W&Q availability, and funding availability with Maine CDC. Apply normal CRM, Atlas_Email_Queue, Email Opt-Out, sent-history, reply, bounce, deadline, approval, and organization+exact-opportunity deduplication controls before any outreach is queued.
Official source: Maine Division of Procurement Services, CT NOI 0220260125, Tuberculosis Consultant.